Sanofi
SNYNF
$84.97
-$1.67-1.93%
OTC PK
| 12/31/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | 13.16B | 11.34B | 10.41B | 10.24B | |
| Total Other Revenue | 1.05B | 840.98M | 748.22M | 833.99M | |
| Total Revenue | 14.21B | 12.18B | 11.16B | 11.08B | |
| Cost of Revenue | 4.23B | 3.40B | 3.04B | 3.48B | |
| Gross Profit | 9.98B | 8.79B | 8.12B | 7.60B | |
| SG&A Expenses | 3.28B | 2.63B | 2.34B | 2.67B | |
| Depreciation & Amortization | 626.28M | 429.00M | 419.89M | 436.29M | |
| Other Operating Expenses | 1.38B | 1.62B | 1.15B | 691.01M | |
| Total Operating Expenses | 12.18B | 10.24B | 8.85B | 9.51B | |
| Operating Income | 2.03B | 1.94B | 2.31B | 1.56B | |
| Income Before Tax | -1.34B | 1.66B | 2.32B | 686.71M | |
| Income Tax Expenses | -405.11M | 261.03M | 506.18M | 114.79M | |
| Earnings from Continuing Operations | -939.43M | 1.40B | 1.81B | 571.92M | |
| Earnings from Discontinued Operations | 15.13M | 3.07B | 183.11M | -197.83M | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -8.15M | -4.54M | -22.10M | -11.25M | |
| Net Income | -932.44M | 4.47B | 1.97B | 362.84M | |
| EBIT | 2.03B | 1.94B | 2.31B | 1.56B | |
| EBITDA | 4.06B | 2.82B | 2.73B | 3.11B | |
| EPS Basic | -0.77 | 3.67 | 1.60 | 0.29 | |
| Normalized Basic EPS | 1.02 | 1.01 | -- | -- | |
| EPS Diluted | -0.77 | 3.67 | 1.60 | 0.28 | |
| Normalized Diluted EPS | 1.02 | 1.01 | -- | -- | |
| Average Basic Shares Outstanding | 1.21B | 1.22B | 1.23B | 1.25B | |
| Average Diluted Shares Outstanding | 1.21B | 1.22B | 1.23B | 1.26B | |
| Dividend Per Share | 4.80 | -- | -- | 4.18 | |
| Payout Ratio | -595.76% | 121.12% | -- | 84.60% | |